Clinical, FDG-PET and molecular markers of immune checkpoint inhibitor response in patients with metastatic Merkel cell carcinoma.

Alison M WepplerAndrew PattisonPrachi BhavePaolo De IesoJeanette RaleighAthena HatzimihalisAnthony J GillShiva BalachanderJason CallahanMargaret ChuaGeorge Au-YeungGrant A McArthurRodney J HicksRichard W TothillShahneen Sandhu

Published in: Journal for immunotherapy of cancer (2021)

ICIs showed efficacy and safety in mMCC consistent with trial data. Clinical and imaging predictors of response were identified.

Keyphrases

pet ct
positron emission tomography
pet imaging
computed tomography
high resolution
clinical trial
study protocol
electronic health record
phase iii
phase ii
mass spectrometry